#United States #medical cannabis #Mississippi #MoreBetter

MoreBetter Launches Statewide Medical Cannabis Program

On November 10, 2026, MoreBetter, Ltd. announced a groundbreaking initiative in Mississippi, marking the state's first-of-its-kind program dedicated to gathering patient-reported outcomes within the realm of medical cannabis. This initiative aims to create a robust framework that offers insights to regulators, stakeholders, and researchers about the impacts of medical cannabis on health outcomes, prescription use, and overall quality of life.

As more than 66,000 active patients registered with Mississippi's medical cannabis program by the close of 2025, the urgency for detailed patient-level data has never been more critical. The program is designed to provide a comprehensive view on how medical cannabis impacts symptoms management, medication usage, and various health outcomes. This direct participation empowers the state and research partners with continuous access to valuable real-world evidence.

Aiming for Real-World Evidence

MoreBetter is obligated to establish an evidence infrastructure that will facilitate the design and management of the study while ensuring meaningful participant interactions. This includes collecting extensive data, cooperating with academic partners for analysis, and ultimately publishing findings. These efforts are not isolated, as MoreBetter has plans for similar programs across over a dozen states, including Pennsylvania and Illinois, bringing forth a national incentive for comprehensive health outcome data regarding medical cannabis.

The fundamental objective of the program is to answer practical questions for regulators and lawmakers. These inquiries range from whether medical cannabis utilization correlates with a decrease in prescription medication over time to understanding variations in responses based on specific health conditions. Given the evolving landscape of medical cannabis policies, this initiative is positioned to fulfill an essential gap in understanding the therapy’s effectiveness.

Research Integrity and Data Governance

What sets this program apart is its commitment to using research-grade methodologies and validated instruments that offer a high degree of reliability and accuracy in results. Responses from patients will be pooled into a centralized statewide dataset, allowing for insights that are closely vetted by institutional review boards and designed with strong data governance policies. Such structure adheres to rigorous regulatory frameworks, addressing privacy while simultaneously yielding essential data needed by lawmakers and healthcare organizations.

Patient recruitment for the initiative is anticipated to commence in the first quarter of 2027. MoreBetter is actively inviting participation from cannabis manufacturers, dispensary operators, and relevant organizations across various states, fostering a community-wide involvement in enhancing understanding of medical cannabis.

Aligning with Stakeholders

As noted by Kevin Provost, CEO of MoreBetter, the questions being posed resonate across all states with operational medical cannabis markets, stressing the demand for a structured evidence-based approach. Beyond Mississippi, the program aims to replicate its model in cooperation with states such as Florida, California, and Georgia, facilitating a broad-based understanding of patient experiences and health outcomes related to cannabis use.

Looking Ahead

MoreBetter is keen on linking patient-reported outcomes to electronic health records and claims data in compliance with HIPAA regulations, thereby providing a more holistic view of patient health while safeguarding confidentiality. Importantly, the initiative is framed as observational research, refraining from claims about cannabis as a treatment modality for medical conditions. This transparency is pivotal in promoting realistic expectations regarding cannabis and patient welfare.

In conclusion, as Mississippi adopts this innovative program, it highlights a significant advance in the medical cannabis sector that could serve as a blueprint for other states. MoreBetter's effort to integrate patient feedback into a scientific framework not only paves the way for informed policymaking but expresses a newfound commitment to understanding and improving patient care in the realm of medical cannabis.

For further details about participating or engaging with the program as it unfolds, those interested may reach out to MoreBetter through their website or directly via their contact information. This initiative is set to reshape the discourse surrounding medical cannabis and generate critical evidence for future health policies.